1-3 of 3
Megan Melody, MD
Close
Sort by
Journal Articles

Management of Patients with Aggressive B Cell Non-Hodgkin Lymphoma after Relapse from Axicabtagene Ciloleucel: Single Center Real-World Experience

Jose V. Forero, MD, Paula A. Lengerke Diaz, MD, Eider F. Moreno Cortes, MD, Megan Melody, MD, Allison C. Rosenthal, D.O., Mohamed A. Kharfan-Dabaja, MDMBA, Januario E. Castro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-143168
Published: 2020
Journal Articles

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

Megan Melody, MD, Sangeetha Gandhi, MBBS, Zaid Abdel Rahman, MD, Paula A Lengerke Diaz, MD, Nicole Gannon, PA-C, Allison C. Rosenthal, DO, Tuan Truong, Mattia Novo, Eva Brandes, Gina Lange, Breanna Estby, RN, Patrick Johnston, MD PhD, Stephen M Ansell, MD PhD, N. Nora Bennani, MD, Jonas Paludo, MD, Jose Villasboas, MD, Ernesto Ayala, MD, Han W. Tun, MD, Hemant S. Murthy, MD, Vivek Roy, MD, James M. Foran, MD, Januario E. Castro, MD, Yi Lin, MD PhD, Mohamed A Kharfan-Dabaja, MDMBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5343.
https://doi.org/10.1182/blood-2019-126594
Published: 2019
Journal Articles

Impact of Anti-CD19 CAR-T Axicabtagene Ciloleucel on Vaccine Titers of DTaP and MMR

Zaid Abdel Rahman, MD, Nicole Gannon, PA-C, Megan Melody, MD, Paul Muniz, RN, Ernesto Ayala, MD, Vivek Roy, MD, Lisa Brumble, Sikander Ailawadhi, MD, Taimur Sher, MD, James M. Foran, MD, Hemant S. Murthy, MD, Han W. Tun, MD, Candido E. Rivera, MD, Asher A. Chanan-Khan, MD, Abba C. Zubair, MD PhD, Mohamed A Kharfan-Dabaja, MDMBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5610.
https://doi.org/10.1182/blood-2019-122067
Published: 2019